Predictors of outcome in heart failure patients with severe functional mitral regurgitation undergoing MitraClip treatment

The prognostic predictors of outcome in patients with functional mitral regurgitation (FMR) undergoing MitraClip implantation (MCi) are still poorly known. The aim of our study is to identify the baseline predictors of outcome in FMR patients candidate to MCi. All patients with symptomatic moderate-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of cardiology 2019-06, Vol.284, p.50-58
Hauptverfasser: Baldi, Cesare, Citro, Rodolfo, Silverio, Angelo, Di Maio, Marco, De Rosa, Roberta, Bonadies, Domenico, Verolino, Giuseppe, Esposito, Luca, Mastrogiovanni, Generoso, Di Muro, Michele Roberto, Piscione, Federico, Galasso, Gennaro
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 58
container_issue
container_start_page 50
container_title International journal of cardiology
container_volume 284
creator Baldi, Cesare
Citro, Rodolfo
Silverio, Angelo
Di Maio, Marco
De Rosa, Roberta
Bonadies, Domenico
Verolino, Giuseppe
Esposito, Luca
Mastrogiovanni, Generoso
Di Muro, Michele Roberto
Piscione, Federico
Galasso, Gennaro
description The prognostic predictors of outcome in patients with functional mitral regurgitation (FMR) undergoing MitraClip implantation (MCi) are still poorly known. The aim of our study is to identify the baseline predictors of outcome in FMR patients candidate to MCi. All patients with symptomatic moderate-to-severe or severe FMR undergoing MCi at our institution were consecutively and prospectively enrolled. Baseline clinical and instrumental data were collected. Primary endpoint was the occurrence of cardiac death; secondary endpoints were all-cause death and the composite of cardiac death or rehospitalization for heart failure. 74 patients (mean 71.6 ± 8.3 years) were enrolled. During follow-up (median 416.0 days), the primary endpoint occurred in 15 (20.3%), all-cause death in 26 (35.1%) and the composite endpoint in 25 (33.8%). At multivariate analysis, the left atrial volume index (LAVi; HR:1.02; P = 0.048) and the low peak oxygen uptake (peak VO2; HR:0.73; P = 0.018) increased the risk of cardiac death at follow-up; atrial fibrillation (AF; HR:2.69; P = 0.027) was independently associated to all-cause death and the low level of peak VO2 was an independent predictor of overall mortality (HR:0.70; P 
doi_str_mv 10.1016/j.ijcard.2018.10.055
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2126910340</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0167527318326378</els_id><sourcerecordid>2126910340</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-72d92908e34b648df4f6a263157b85d2b9137b3577cc0af7dbfe9b829a30a74d3</originalsourceid><addsrcrecordid>eNp9kE1v1DAQhi0EotuWf4CQj1yy9Vfi-FIJrQpUKoIDPVuOPd56lcSL7RTBr8fRthx7GumdZ2Y0D0LvKdlSQrurwzYcrEluywjta7QlbfsKbWgvRUNlK16jTcVk0zLJz9B5zgdCiFCqf4vOOOEdUardoL8_ErhgS0wZR4_jUmycAIcZP4BJBXsTxiUBPpoSYC4Z_w7lAWd4hBr6ZbYlxNmMeAol1ZJgv6R9KGaN8TI7SPsY5j3-tvZ3YzjiksCUqe66RG-8GTO8e6oX6P7zzc_d1-bu-5fb3ae7xvKOlUYyp5giPXAxdKJ3XvjOsI7TVg5969igKJcDb6W0lhgv3eBBDT1ThhMjheMX6ONp7zHFXwvkoqeQLYyjmSEuWTPKOkUJF6Si4oTaFHNO4PUxhcmkP5oSvVrXB32yrlfra1qt17EPTxeWYQL3f-hZcwWuTwDUPx8DJJ1t1Wmr-gS2aBfDyxf-AS_KmBQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2126910340</pqid></control><display><type>article</type><title>Predictors of outcome in heart failure patients with severe functional mitral regurgitation undergoing MitraClip treatment</title><source>Elsevier ScienceDirect Journals Complete - AutoHoldings</source><source>MEDLINE</source><creator>Baldi, Cesare ; Citro, Rodolfo ; Silverio, Angelo ; Di Maio, Marco ; De Rosa, Roberta ; Bonadies, Domenico ; Verolino, Giuseppe ; Esposito, Luca ; Mastrogiovanni, Generoso ; Di Muro, Michele Roberto ; Piscione, Federico ; Galasso, Gennaro</creator><creatorcontrib>Baldi, Cesare ; Citro, Rodolfo ; Silverio, Angelo ; Di Maio, Marco ; De Rosa, Roberta ; Bonadies, Domenico ; Verolino, Giuseppe ; Esposito, Luca ; Mastrogiovanni, Generoso ; Di Muro, Michele Roberto ; Piscione, Federico ; Galasso, Gennaro</creatorcontrib><description>The prognostic predictors of outcome in patients with functional mitral regurgitation (FMR) undergoing MitraClip implantation (MCi) are still poorly known. The aim of our study is to identify the baseline predictors of outcome in FMR patients candidate to MCi. All patients with symptomatic moderate-to-severe or severe FMR undergoing MCi at our institution were consecutively and prospectively enrolled. Baseline clinical and instrumental data were collected. Primary endpoint was the occurrence of cardiac death; secondary endpoints were all-cause death and the composite of cardiac death or rehospitalization for heart failure. 74 patients (mean 71.6 ± 8.3 years) were enrolled. During follow-up (median 416.0 days), the primary endpoint occurred in 15 (20.3%), all-cause death in 26 (35.1%) and the composite endpoint in 25 (33.8%). At multivariate analysis, the left atrial volume index (LAVi; HR:1.02; P = 0.048) and the low peak oxygen uptake (peak VO2; HR:0.73; P = 0.018) increased the risk of cardiac death at follow-up; atrial fibrillation (AF; HR:2.69; P = 0.027) was independently associated to all-cause death and the low level of peak VO2 was an independent predictor of overall mortality (HR:0.70; P &lt; 0.001) as well as of the composite endpoint (HR:0.73; P &lt; 0.001). The ROC analysis identified a peak VO2 cut-off of 10.0 mL/kg/min as the best predictor for the three study endpoints; the best LAVi cut-off for cardiac death was 67 mL/m2. Kaplan-Meier analysis for the individual and combined outcome predictors confirmed their significant stratification ability during follow-up. Peak VO2, along with LAVi and AF, identify FMR patients with the worst prognosis after MCi. •The MCi eligibility of FMR patients needs a multiparametric evaluation to avoid futility.•Baseline peak VO2, LAVi and AF are independent predictors of events after MCi.•In FMR patients peak VO2 &lt; 10 mL/kg/min carried the worst prognosis after MCi.</description><identifier>ISSN: 0167-5273</identifier><identifier>EISSN: 1874-1754</identifier><identifier>DOI: 10.1016/j.ijcard.2018.10.055</identifier><identifier>PMID: 30360995</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Aged ; Atrial fibrillation ; Cardiopulmonary exercise test ; Disease Progression ; Echocardiography ; Female ; Follow-Up Studies ; Functional mitral regurgitation ; Heart failure ; Heart Failure - complications ; Heart Failure - epidemiology ; Heart Failure - physiopathology ; Heart Valve Prosthesis Implantation - methods ; Humans ; Incidence ; Italy - epidemiology ; Male ; MitraClip ; Mitral Valve - diagnostic imaging ; Mitral Valve - surgery ; Mitral Valve Insufficiency - diagnosis ; Mitral Valve Insufficiency - etiology ; Mitral Valve Insufficiency - surgery ; Percutaneous mitral valve repair ; Prognosis ; Prospective Studies ; Prosthesis Design ; Risk Assessment - methods ; Risk Factors ; Severity of Illness Index ; Survival Rate - trends ; Treatment Outcome ; Ventricular Function, Left - physiology</subject><ispartof>International journal of cardiology, 2019-06, Vol.284, p.50-58</ispartof><rights>2018</rights><rights>Copyright © 2018. Published by Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-72d92908e34b648df4f6a263157b85d2b9137b3577cc0af7dbfe9b829a30a74d3</citedby><cites>FETCH-LOGICAL-c362t-72d92908e34b648df4f6a263157b85d2b9137b3577cc0af7dbfe9b829a30a74d3</cites><orcidid>0000-0003-3622-4965</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ijcard.2018.10.055$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3549,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30360995$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Baldi, Cesare</creatorcontrib><creatorcontrib>Citro, Rodolfo</creatorcontrib><creatorcontrib>Silverio, Angelo</creatorcontrib><creatorcontrib>Di Maio, Marco</creatorcontrib><creatorcontrib>De Rosa, Roberta</creatorcontrib><creatorcontrib>Bonadies, Domenico</creatorcontrib><creatorcontrib>Verolino, Giuseppe</creatorcontrib><creatorcontrib>Esposito, Luca</creatorcontrib><creatorcontrib>Mastrogiovanni, Generoso</creatorcontrib><creatorcontrib>Di Muro, Michele Roberto</creatorcontrib><creatorcontrib>Piscione, Federico</creatorcontrib><creatorcontrib>Galasso, Gennaro</creatorcontrib><title>Predictors of outcome in heart failure patients with severe functional mitral regurgitation undergoing MitraClip treatment</title><title>International journal of cardiology</title><addtitle>Int J Cardiol</addtitle><description>The prognostic predictors of outcome in patients with functional mitral regurgitation (FMR) undergoing MitraClip implantation (MCi) are still poorly known. The aim of our study is to identify the baseline predictors of outcome in FMR patients candidate to MCi. All patients with symptomatic moderate-to-severe or severe FMR undergoing MCi at our institution were consecutively and prospectively enrolled. Baseline clinical and instrumental data were collected. Primary endpoint was the occurrence of cardiac death; secondary endpoints were all-cause death and the composite of cardiac death or rehospitalization for heart failure. 74 patients (mean 71.6 ± 8.3 years) were enrolled. During follow-up (median 416.0 days), the primary endpoint occurred in 15 (20.3%), all-cause death in 26 (35.1%) and the composite endpoint in 25 (33.8%). At multivariate analysis, the left atrial volume index (LAVi; HR:1.02; P = 0.048) and the low peak oxygen uptake (peak VO2; HR:0.73; P = 0.018) increased the risk of cardiac death at follow-up; atrial fibrillation (AF; HR:2.69; P = 0.027) was independently associated to all-cause death and the low level of peak VO2 was an independent predictor of overall mortality (HR:0.70; P &lt; 0.001) as well as of the composite endpoint (HR:0.73; P &lt; 0.001). The ROC analysis identified a peak VO2 cut-off of 10.0 mL/kg/min as the best predictor for the three study endpoints; the best LAVi cut-off for cardiac death was 67 mL/m2. Kaplan-Meier analysis for the individual and combined outcome predictors confirmed their significant stratification ability during follow-up. Peak VO2, along with LAVi and AF, identify FMR patients with the worst prognosis after MCi. •The MCi eligibility of FMR patients needs a multiparametric evaluation to avoid futility.•Baseline peak VO2, LAVi and AF are independent predictors of events after MCi.•In FMR patients peak VO2 &lt; 10 mL/kg/min carried the worst prognosis after MCi.</description><subject>Aged</subject><subject>Atrial fibrillation</subject><subject>Cardiopulmonary exercise test</subject><subject>Disease Progression</subject><subject>Echocardiography</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Functional mitral regurgitation</subject><subject>Heart failure</subject><subject>Heart Failure - complications</subject><subject>Heart Failure - epidemiology</subject><subject>Heart Failure - physiopathology</subject><subject>Heart Valve Prosthesis Implantation - methods</subject><subject>Humans</subject><subject>Incidence</subject><subject>Italy - epidemiology</subject><subject>Male</subject><subject>MitraClip</subject><subject>Mitral Valve - diagnostic imaging</subject><subject>Mitral Valve - surgery</subject><subject>Mitral Valve Insufficiency - diagnosis</subject><subject>Mitral Valve Insufficiency - etiology</subject><subject>Mitral Valve Insufficiency - surgery</subject><subject>Percutaneous mitral valve repair</subject><subject>Prognosis</subject><subject>Prospective Studies</subject><subject>Prosthesis Design</subject><subject>Risk Assessment - methods</subject><subject>Risk Factors</subject><subject>Severity of Illness Index</subject><subject>Survival Rate - trends</subject><subject>Treatment Outcome</subject><subject>Ventricular Function, Left - physiology</subject><issn>0167-5273</issn><issn>1874-1754</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1v1DAQhi0EotuWf4CQj1yy9Vfi-FIJrQpUKoIDPVuOPd56lcSL7RTBr8fRthx7GumdZ2Y0D0LvKdlSQrurwzYcrEluywjta7QlbfsKbWgvRUNlK16jTcVk0zLJz9B5zgdCiFCqf4vOOOEdUardoL8_ErhgS0wZR4_jUmycAIcZP4BJBXsTxiUBPpoSYC4Z_w7lAWd4hBr6ZbYlxNmMeAol1ZJgv6R9KGaN8TI7SPsY5j3-tvZ3YzjiksCUqe66RG-8GTO8e6oX6P7zzc_d1-bu-5fb3ae7xvKOlUYyp5giPXAxdKJ3XvjOsI7TVg5969igKJcDb6W0lhgv3eBBDT1ThhMjheMX6ONp7zHFXwvkoqeQLYyjmSEuWTPKOkUJF6Si4oTaFHNO4PUxhcmkP5oSvVrXB32yrlfra1qt17EPTxeWYQL3f-hZcwWuTwDUPx8DJJ1t1Wmr-gS2aBfDyxf-AS_KmBQ</recordid><startdate>20190601</startdate><enddate>20190601</enddate><creator>Baldi, Cesare</creator><creator>Citro, Rodolfo</creator><creator>Silverio, Angelo</creator><creator>Di Maio, Marco</creator><creator>De Rosa, Roberta</creator><creator>Bonadies, Domenico</creator><creator>Verolino, Giuseppe</creator><creator>Esposito, Luca</creator><creator>Mastrogiovanni, Generoso</creator><creator>Di Muro, Michele Roberto</creator><creator>Piscione, Federico</creator><creator>Galasso, Gennaro</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3622-4965</orcidid></search><sort><creationdate>20190601</creationdate><title>Predictors of outcome in heart failure patients with severe functional mitral regurgitation undergoing MitraClip treatment</title><author>Baldi, Cesare ; Citro, Rodolfo ; Silverio, Angelo ; Di Maio, Marco ; De Rosa, Roberta ; Bonadies, Domenico ; Verolino, Giuseppe ; Esposito, Luca ; Mastrogiovanni, Generoso ; Di Muro, Michele Roberto ; Piscione, Federico ; Galasso, Gennaro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-72d92908e34b648df4f6a263157b85d2b9137b3577cc0af7dbfe9b829a30a74d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Aged</topic><topic>Atrial fibrillation</topic><topic>Cardiopulmonary exercise test</topic><topic>Disease Progression</topic><topic>Echocardiography</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Functional mitral regurgitation</topic><topic>Heart failure</topic><topic>Heart Failure - complications</topic><topic>Heart Failure - epidemiology</topic><topic>Heart Failure - physiopathology</topic><topic>Heart Valve Prosthesis Implantation - methods</topic><topic>Humans</topic><topic>Incidence</topic><topic>Italy - epidemiology</topic><topic>Male</topic><topic>MitraClip</topic><topic>Mitral Valve - diagnostic imaging</topic><topic>Mitral Valve - surgery</topic><topic>Mitral Valve Insufficiency - diagnosis</topic><topic>Mitral Valve Insufficiency - etiology</topic><topic>Mitral Valve Insufficiency - surgery</topic><topic>Percutaneous mitral valve repair</topic><topic>Prognosis</topic><topic>Prospective Studies</topic><topic>Prosthesis Design</topic><topic>Risk Assessment - methods</topic><topic>Risk Factors</topic><topic>Severity of Illness Index</topic><topic>Survival Rate - trends</topic><topic>Treatment Outcome</topic><topic>Ventricular Function, Left - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Baldi, Cesare</creatorcontrib><creatorcontrib>Citro, Rodolfo</creatorcontrib><creatorcontrib>Silverio, Angelo</creatorcontrib><creatorcontrib>Di Maio, Marco</creatorcontrib><creatorcontrib>De Rosa, Roberta</creatorcontrib><creatorcontrib>Bonadies, Domenico</creatorcontrib><creatorcontrib>Verolino, Giuseppe</creatorcontrib><creatorcontrib>Esposito, Luca</creatorcontrib><creatorcontrib>Mastrogiovanni, Generoso</creatorcontrib><creatorcontrib>Di Muro, Michele Roberto</creatorcontrib><creatorcontrib>Piscione, Federico</creatorcontrib><creatorcontrib>Galasso, Gennaro</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Baldi, Cesare</au><au>Citro, Rodolfo</au><au>Silverio, Angelo</au><au>Di Maio, Marco</au><au>De Rosa, Roberta</au><au>Bonadies, Domenico</au><au>Verolino, Giuseppe</au><au>Esposito, Luca</au><au>Mastrogiovanni, Generoso</au><au>Di Muro, Michele Roberto</au><au>Piscione, Federico</au><au>Galasso, Gennaro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Predictors of outcome in heart failure patients with severe functional mitral regurgitation undergoing MitraClip treatment</atitle><jtitle>International journal of cardiology</jtitle><addtitle>Int J Cardiol</addtitle><date>2019-06-01</date><risdate>2019</risdate><volume>284</volume><spage>50</spage><epage>58</epage><pages>50-58</pages><issn>0167-5273</issn><eissn>1874-1754</eissn><abstract>The prognostic predictors of outcome in patients with functional mitral regurgitation (FMR) undergoing MitraClip implantation (MCi) are still poorly known. The aim of our study is to identify the baseline predictors of outcome in FMR patients candidate to MCi. All patients with symptomatic moderate-to-severe or severe FMR undergoing MCi at our institution were consecutively and prospectively enrolled. Baseline clinical and instrumental data were collected. Primary endpoint was the occurrence of cardiac death; secondary endpoints were all-cause death and the composite of cardiac death or rehospitalization for heart failure. 74 patients (mean 71.6 ± 8.3 years) were enrolled. During follow-up (median 416.0 days), the primary endpoint occurred in 15 (20.3%), all-cause death in 26 (35.1%) and the composite endpoint in 25 (33.8%). At multivariate analysis, the left atrial volume index (LAVi; HR:1.02; P = 0.048) and the low peak oxygen uptake (peak VO2; HR:0.73; P = 0.018) increased the risk of cardiac death at follow-up; atrial fibrillation (AF; HR:2.69; P = 0.027) was independently associated to all-cause death and the low level of peak VO2 was an independent predictor of overall mortality (HR:0.70; P &lt; 0.001) as well as of the composite endpoint (HR:0.73; P &lt; 0.001). The ROC analysis identified a peak VO2 cut-off of 10.0 mL/kg/min as the best predictor for the three study endpoints; the best LAVi cut-off for cardiac death was 67 mL/m2. Kaplan-Meier analysis for the individual and combined outcome predictors confirmed their significant stratification ability during follow-up. Peak VO2, along with LAVi and AF, identify FMR patients with the worst prognosis after MCi. •The MCi eligibility of FMR patients needs a multiparametric evaluation to avoid futility.•Baseline peak VO2, LAVi and AF are independent predictors of events after MCi.•In FMR patients peak VO2 &lt; 10 mL/kg/min carried the worst prognosis after MCi.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>30360995</pmid><doi>10.1016/j.ijcard.2018.10.055</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0003-3622-4965</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0167-5273
ispartof International journal of cardiology, 2019-06, Vol.284, p.50-58
issn 0167-5273
1874-1754
language eng
recordid cdi_proquest_miscellaneous_2126910340
source Elsevier ScienceDirect Journals Complete - AutoHoldings; MEDLINE
subjects Aged
Atrial fibrillation
Cardiopulmonary exercise test
Disease Progression
Echocardiography
Female
Follow-Up Studies
Functional mitral regurgitation
Heart failure
Heart Failure - complications
Heart Failure - epidemiology
Heart Failure - physiopathology
Heart Valve Prosthesis Implantation - methods
Humans
Incidence
Italy - epidemiology
Male
MitraClip
Mitral Valve - diagnostic imaging
Mitral Valve - surgery
Mitral Valve Insufficiency - diagnosis
Mitral Valve Insufficiency - etiology
Mitral Valve Insufficiency - surgery
Percutaneous mitral valve repair
Prognosis
Prospective Studies
Prosthesis Design
Risk Assessment - methods
Risk Factors
Severity of Illness Index
Survival Rate - trends
Treatment Outcome
Ventricular Function, Left - physiology
title Predictors of outcome in heart failure patients with severe functional mitral regurgitation undergoing MitraClip treatment
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T09%3A20%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Predictors%20of%20outcome%20in%20heart%20failure%20patients%20with%20severe%20functional%20mitral%20regurgitation%20undergoing%20MitraClip%20treatment&rft.jtitle=International%20journal%20of%20cardiology&rft.au=Baldi,%20Cesare&rft.date=2019-06-01&rft.volume=284&rft.spage=50&rft.epage=58&rft.pages=50-58&rft.issn=0167-5273&rft.eissn=1874-1754&rft_id=info:doi/10.1016/j.ijcard.2018.10.055&rft_dat=%3Cproquest_cross%3E2126910340%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2126910340&rft_id=info:pmid/30360995&rft_els_id=S0167527318326378&rfr_iscdi=true